Analogues of N3-Pyridyl Thiamine: Biochemical Evaluation, Computational Analysis, and Anti-plasmodial Activity

Read full text Summarise with VIRAT
Authors: Terence C. S. Ho, Alex H. Y. Chan, Imam Fathoni, Kevin J. Saliba, Finian J. Leeper
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Thiamine is metabolized into the coenzyme thiamine pyrophosphate (TPP). Interruption of thiamine utilization results in disease states. Oxythiamine is an anti-thiamine which enters cells through transporters, undergoes enzymatic phosphorylation, and then inhibits TPP-dependent enzymes. In 2013, oxythiamine was used as a chemical tool to establish the thiamine utilization pathway as a drug target for the development of anti-malarial agents. More recently, we discovered another anti-thiamine compound, N3-pyridyl thiamine (N3PT), which shares a similar mode of action against Plasmodium with oxythiamine, while exhibiting greater potency and lower toxicity. Given its promising potential as an anti-malarial agent, we designed and synthesised analogues of N3PT in this study and then profiled their inhibition of TPP-dependent enzymes and of P. falciparum proliferation.

Fields of Study & Subjects

Malaria Research and Control Heterocyclic Compound Synthesis and Bioactivity Biochemical Acid Research Studies

Publication details

Journal / source
ChemRxiv
Publication date
22 March 2026
Language
EN
Document type
Preprint